New Lifescience Underwriting Expertise and Capacity





Newly created MGA Nucleus Underwriting brings a fresh underwriting approach and much needed expertise for insurance intermediaries unafraid of the Lifescience sector.

Nucleus Underwriting unveils its insurance solutions for European SME Lifescience businesses.

As a broker-only MGA, Nucleus Underwriting supplies specialist risk solutions for businesses operating in and providing support to the pharmaceutical, bioscience, medical technology, dietary supplement and cosmetic sectors.

Nucleus underwrites on behalf of a variety of Lloyds Syndicates, delivering covers for Public Liability, Products and Services Liability, Products and Services Professional Liability; Clinical Trials, Employer's Liability, Material Damage, Business Interruption, and Directors' & Officers' Liability.

Highly experienced Underwriting Director, James McHugh, commented that: "The expertise and capabilities at Nucleus Underwriting and a genuine commitment to superior service, provides a very attractive proposition for brokers. Our offerings show the strength of the MGA model in delivering specialist insurance products and services."

To find out more about the products and services on offer visit nucleusunderwriting.com

About Nucleus Underwriting:

Nucleus Underwriting is a specialist Managing General Agent underwriting on behalf of Mitsui Sumitomo Syndicate 3210 and Kiln Syndicate 510 at Lloyds.

We provide access to specialist Underwriting expertise and bespoke products. This coupled with a genuinely high level of service and quick turnaround makes Nucleus Underwriting a great company to do business with.

Target Market

Our focus is UK and European Lifescience businesses.

In a sector where a great deal of attention is on a small number of huge international players it is easy to lose sight of the fact that around 95% of UK Lifescience businesses are SMEs with turnover of less than £50m. Many are significantly below that.

Nucleus Underwriting provides a solution for such businesses in an insurance market which is low on capacity and specialist knowledge.

The Opportunity for Brokers

We want to work with dynamic and forward thinking insurance intermediaries unafraid of the Lifescience sector.

The SME Lifescience sector presents a potentially untapped market for many intermediaries. There is significant sector investment and it provides enormous growth potential.

Nucleus Underwriting can help in guiding intermediaries with little or no sector experience in providing their clients with appropriate and cost effective insurance solutions.

Sector Experience

Underwriting Director, James McHugh, has considerable Lifescience experience, having established and managed for 8 years, the Chubb UK Lifescience account and launched a number of Lifescience products whilst Head of UK Casualty at Catlin.


Underwriting Contact:

James McHugh, Underwriting Director

Direct Dial: 0161 237 7737

E-Mail: james.mchugh@nucleusunderwriting.com

Press Contact:

Martin Jackson, Marketing & Media Director

Direct Dial: 0161 237 7728

E-Mail: martin.jackson@nucleusunderwriting.com

Press release distributed by Pressat on behalf of Nucleus Underwriting, on Wednesday 24 June, 2015. For more information subscribe and follow https://pressat.co.uk/


Lifescience Insurance Pharmaceutical Bioscience Medical Technology Dietary Supplements Cosmetics Public Liability Professional Liability Business & Finance Medical & Pharmaceutical
Published By

Nucleus Underwriting

Nucleus Underwriting
0161 237 7737
james.mchugh@nucleusunderwriting.com
http://www.nucleusunderwriting.com

Visit Newsroom

Media

No media attached. Please contact Nucleus Underwriting for more information.


Additional PR Formats


You just read:

New Lifescience Underwriting Expertise and Capacity